ORBIMED ADVISORS LLC
Q4 2013 13F-HR Holdings
Net value change ($000)
—
New positions
105
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| GILD | 374,944 | — |
| BIIB | 306,159 | — |
| CELG | 296,894 | — |
| BMY | 290,465 | — |
| AMGN | 286,945 | — |
| RELYPSA INC | 248,539 | — |
| INCY | 206,013 | — |
| REGN | 203,347 | — |
| MEDIVATION | 199,342 | — |
| ABBV | 198,613 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
99,063
(1.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|